| Novartis Pharma Schweiz AG - Revolade 25 mg, Filmtabletten | | 60122 | | 01 | | Revolade 25 mg | | Filmtabletten | | B02BX05 | | Eltrombopag | | 23.06.2010 | | |
| | Composition | | eltrombopagum 25 mg ut eltrombopagum olaminum, mannitolum, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.784-1.176 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, polysorbatum 80, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Eltrombopagum | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Eltrombopagum | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Mannitol | | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| |
|
